Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Doxycycline Anhydrous. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP7 known ✓ | P09237 | 1/20 | 0.69 |
| ▸ | MMP8 known ✓ | P22894 | 1/20 | 0.69 |
| ▸ | MMP13 known ✓ | P45452 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 10/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 7/20 | 0.69 |
| ▸ | USP2 | O75604 | 6/20 | 0.69 |
| ▸ | MMP2 | P08253 | 1/20 | 0.69 |
| ▸ | MMP3 | P08254 | 1/20 | 0.69 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.69 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.68 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | RECQL | P46063 | 7/20 | 0.67 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.67 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.67 |
| ▸ | HPGD | P15428 | 7/20 | 0.49 |
| ▸ | MEN1 | O00255 | 6/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Doxycycline Anhydrous SCHEMBL497165 | 1.00 | TDP1 (0.69) | TDP1KDM4EL3MBTL1USP2MMP2 | |
| Doxycycline Anhydrous SCHEMBL17747966 | 1.00 | TDP1 (0.69) | TDP1KDM4EL3MBTL1USP2MMP2 | |
| Doxycycline Anhydrous SCHEMBL229272 | 1.00 | TDP1 (0.69) | TDP1KDM4EL3MBTL1USP2MMP2 | |
| Doxycycline Anhydrous SCHEMBL8709949 | 1.00 | TDP1 (0.69) | TDP1KDM4EL3MBTL1USP2MMP2 | |
| Doxycycline Anhydrous SCHEMBL29151798 | 1.00 | TDP1 (0.69) | TDP1KDM4EL3MBTL1USP2MMP2 | |
| Doxycycline Anhydrous SCHEMBL8709954 | 0.99 | TDP1 (0.70) | TDP1KDM4EL3MBTL1USP2MMP2 | |
| Doxycycline Anhydrous SCHEMBL11417262 | 0.99 | MMP2 (0.70) | TDP1KDM4EL3MBTL1USP2MMP2 | |
| Doxycycline Anhydrous SCHEMBL8683380 | 0.99 | MMP2 (0.70) | TDP1KDM4EL3MBTL1USP2MMP2 | |
| Doxycycline Anhydrous SCHEMBL41883 | 0.99 | MMP2 (0.70) | TDP1KDM4EL3MBTL1USP2MMP2 | |
| Doxycycline Anhydrous SCHEMBL40834 | 0.99 | TDP1 (0.70) | TDP1KDM4EL3MBTL1USP2MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130029943-A1 | Methods of Preparing Substituted Tetracyclines with Transition Metal-Based Chemistries | TRUSTEES OF TUFTS COLLEGE (US) | 2013-01-31 | — | — | US | disclosed |
| US-8106225-B2 | Catalytically reacting a 7(9)- arene tetracycline diazonium salt or an iodotetracycline and a reactive substituent precursor, e.g., (substituted) alkenes, vinyl monomers, aromatics, carbon monoxide; carboxylation, esterification, amidation carbonylation, cyanation; anhydriding; imidation; bactericides | TRUSTEES OF TUFTS COLLEGE (US) | 2012-01-31 | — | — | US | disclosed |
| EP-1666454-B1 | Methods of preparing substituted tetracyclines with transition metal-based chemistries | TUFTS COLLEGE (US) | 2011-09-07 | — | — | EP | disclosed |
| EP-2327686-A2 | Methods of preparing substituted tetracyclines with transition metal-based chemistries | TRUSTEES OF TUFTS COLLEGE (US) | 2011-06-01 | — | — | EP | disclosed |
| EP-2327687-A2 | Methods of preparing substituted tetracyclines with transition metal-based chemistries | TRUSTEES OF TUFTS COLLEGE (US) | 2011-06-01 | — | — | EP | disclosed |
| US-7696187-B2 | Methods of preparing substituted tetracyclines with transition metal-based chemistries | TRUSTEES OF TUFTS COLLEGE (US) | 2010-04-13 | — | — | US | disclosed |
| US-20060166946-A1 | Methods of preparing substituted tetracyclines with transition metal-based chemistries | TRUSTEES OF TUFTS COLLEGE (US) | 2006-07-27 | — | — | US | disclosed |
| US-7067681-B2 | Methods of preparing substituted tetracyclines with transition metal-based chemistries | TRUSTEES OF TUFTS COLLEGE (US) | 2006-06-27 | — | — | US | disclosed |
| EP-1666454-A1 | Methods of preparing substituted tetracyclines with transition metal-based chemistries | TRUSTEES OF TUFTS COLLEGE (US) | 2006-06-07 | — | — | EP | disclosed |
| EP-1666453-A1 | Methods of preparing substituted tetracyclines with transition metal-based chemistries | TRUSTEES OF TUFTS COLLEGE (US) | 2006-06-07 | — | — | EP | disclosed |
| EP-1240133-B1 | METHODS OF PREPARING SUBSTITUTED TETRACYCLINES WITH TRANSITION METAL-BASED CHEMISTRIES | TUFTS COLLEGE (US) | 2006-04-19 | — | — | EP | disclosed |
| US-20050187198-A1 | Methods of preparing substituted tetracyclines with transition metal-based chemistries | TRUSTEES OF TUFTS COLLEGE (US) | 2005-08-25 | — | — | US | disclosed |
| US-20040033996-A1 | Methods of preparing substituted tetracyclines with transition metal-based chemistries | PARATEK PHARMACEUTICALS, INC. | 2004-02-19 | — | — | US | disclosed |
| WO-2003079983-A2 | METHODS OF PREPARING SUBSTITUTED TETRACYCLINES WITH TRANSITION METAL-BASED CHEMISTRIES | TRUSTEES OF TUFTS COLLEGE (US) | 2003-10-02 | — | — | WO | disclosed |
| US-6617318-B1 | 7-substitted tetracyclines are effective against tetracycline-resistant E. coli, S. aureus and E. faecalis strains | TRUSTEES OF TUFTS COLLEGE | 2003-09-09 | — | — | US | disclosed |
| EP-1240133-A1 | METHODS OF PREPARING SUBSTITUTED TETRACYCLINES WITH TRANSITION METAL-BASED CHEMISTRIES | TRUSTEES OF TUFTS COLLEGE (US) | 2002-09-18 | — | — | EP | disclosed |
| WO-2001019784-A1 | METHODS OF PREPARING SUBSTITUTED TETRACYCLINES WITH TRANSITION METAL-BASED CHEMISTRIES | TRUSTEES OF TUFTS COLLEGE (US) | 2001-03-22 | — | — | WO | disclosed |
| EP-0137661-B1 | A NEW PROCESS FOR THE PREPARATION OF ALPHA-6-DEOXY-TETRACYCLINES | HOVIONE INTER LTD. (CH) | 1989-11-02 | — | — | EP | disclosed |
| US-4597904-A | STEREOSELECTIVE HYDROGENATION | HOVIONE INTER LTD. (CH) | 1986-07-01 | — | — | US | disclosed |
| EP-0137661-A2 | A new process for the preparation of alpha-6-deoxy-tetracyclines | HOVIONE INTER LTD. (CH) | 1985-04-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050187198-A1 | Methods of preparing substituted tetracyclines with transition metal-based chemistries | TET1, TET3, DDT | MMP7 2964/4885MMP8 3362/4885MMP13 3774/4885 |
| US-20130029943-A1 | Methods of Preparing Substituted Tetracyclines with Transition Metal-Based Chemistries | TET1, TET3, DDT | MMP7 2964/4885MMP8 3362/4885MMP13 3774/4885 |
| US-20060166946-A1 | Methods of preparing substituted tetracyclines with transition metal-based chemistries | TET1, TET3, DDT | MMP7 2655/4885MMP8 2997/4885MMP13 3654/4885 |
| US-20040033996-A1 | Methods of preparing substituted tetracyclines with transition metal-based chemistries | TET1, TET3, DDT | MMP7 2655/4885MMP8 2997/4885MMP13 3654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.